Stay updated on Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial
Sign up to get notified when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.

Latest updates to the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 on the page footer. This is a minor site update and does not change the study details or user-facing content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedLocations are now listed under a single Locations section with sites across US states and Canadian provinces; the page shows a Revision: v3.3.3.SummaryDifference2%

- Check45 days agoChange DetectedRevision: v3.3.2 has been added and the previous v3.3.1 revision has been removed.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded a note that publications are automatically pulled from PubMed and may not relate to the study, and updated the revision to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe notice about a lapse in government funding was removed from the page. This is a non-significant change to page messaging; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check74 days agoChange DetectedNo meaningful changes detected in the Study Details page between the two screenshots; core information remains the same.SummaryDifference0.3%

Stay in the know with updates to Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.